Italian-Founded Startup Targets “Zombie Cells” to Slow Biological Aging
A 46% reduction in precancerous skin lesions in just four weeks with minimal side effects. Those are the preliminary clinical trial results for a topical cream developed by Rubedo Life Sciences, an AI-driven Silicon Valley biotech founded by Italian researchers. The startup has raised more than $70 million to…